CFM
ALNY icon

Coronation Fund Managers’s Alnylam Pharmaceuticals ALNY Stock Holding History

Coronation Fund Managers’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-98,147
Closed -$11.3M – 74
2019
Q4 		$11.3M Sell
98,147
-35,024
-26% -$3.49M 0.38% 44
2019
Q3 		$10.7M Sell
133,171
-46,439
-26% -$3.67M 0.4% 43
2019
Q2 		$13M Buy
179,610
+53,460
+42% +$4.1M 0.48% 40
2019
Q1 		$11.8M Buy
+126,150
New +$10.6M 0.43% 39

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Coronation Fund Managers's ALNY Position: Q1 2020 in Review

Coronation Fund Managers sold out of Alnylam Pharmaceuticals (ALNY) in Q1 2020, closing a stake of 98,147 shares — an estimated $11.3M sold.

Coronation Fund Managers first reported a position in ALNY in Q1 2019 and held it in 4 quarters. The position peaked at $13M in Q2 2019. 331 funds tracked by Wall St. Rank hold ALNY as of Q1 2020.

  • Coronation Fund Managers reported no remaining Alnylam Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Coronation Fund Managers sold 98,147 Alnylam Pharmaceuticals shares in Q1 2020, an estimated $11.3M.
  • Coronation Fund Managers first reported a position in Alnylam Pharmaceuticals in Q1 2019 and held it in 4 quarters.
  • Coronation Fund Managers's Alnylam Pharmaceuticals position peaked at $13M in Q2 2019.
  • 331 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2020.

Based on Coronation Fund Managers's 13F filing for Q1 2020, filed 12 May 2020.